Menu

Experience

Francis Wheeler

    • Vaxcyte - $288 Milion IPO 


    • 1Life Healthcare - $282 Million IPO 


    • Reata Pharmaceuticals – $505 Million Follow-On Offering 


    • argenx – $557 Million Follow-On Offering 


    • Guild Education Closes $157 Million Series D 


    • Fangdd $78 Million – IPO 


    • Manchester Financial Closes $425 Million Refinance of Fairmont Austin Hotel 


    • Vir Biotechnology - $143 Million IPO 


    • Uber Closes SoftBank Investment 


    • ERYTECH – $144 Million IPO 


    • Semiconductor Developer Aquantia Closes $71 Million IPO 


    • Cooley Advises on Nightstar + NuCana IPOs 


    • Cooley Advised Jazz Pharmaceuticals on Rule 144A Offering of $575 Million of Exchangeable Senior Notes 


    • Zealand Pharma – $89 Million IPO 


    • Aridis – $26 Million IPO 


    • ERYTECH Closes €70.5 Million Private Placement to US + European Investors 


    • Recro Pharma – $15 Million Follow-On  


    • Selecta Biosciences – $74 Million IPO 


    • Oncobiologics – $40 Million IPO and Private Placement 


    • AveXis – $95 Million IPO 


    • Cooley Advises ERYTECH on €25.4 Million Private Placement 


    • ERYTECH Private Placement 


    • Aclaris Therapeutics IPO 


    • T2 Biosystems IPO 


    • Jazz Pharmaceuticals plc Rule 144A Offering of $575 Million of Exchangeable Senior Notes 


    • GlobeImmune Initial Public Offering 


    • Jazz Pharmaceuticals – $575 Million Exchangeable Senior Note Offering 


    • Rally Initial Public Offering 


    • Minerva – $58 Million Follow-On Offering 


    • Merus IPO – $61 Million 


Contact us

Back to top

© 2020 Cooley LLP and Cooley (UK) LLP. All rights reserved.

Cooley® is a registered service mark of Cooley LLP in the United States and European Union as well as certain other jurisdictions.